• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 30, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

ILC 2017: Four new EASL clinical practice guidelines on the management of liver diseases

Bioengineer by Bioengineer
April 19, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

April 19, 2017, Amsterdam, The Netherlands: The European Association for the Study of the Liver (EASL) today announced that four new Clinical Practice Guidelines (CPGs) will be presented at The International Liver Congress™ 2017 in Amsterdam, The Netherlands, and published in the Journal of Hepatology, EASL's official journal.

CPGs define the use of diagnostic, therapeutic and preventive modalities, including non-invasive and invasive procedures, in the management of patients with various liver diseases. They are intended to assist physicians and other healthcare providers, as well as patients and interested individuals, in the clinical decision making process by describing a range of generally accepted approaches for the diagnosis, treatment and prevention of specific liver diseases.

The new CPGs include:

Revised guidelines on the 'Management of Hepatitis B virus infection'

  • Session title: CPG session – HBV
  • Time and date of presentation: Thursday 20 April 2017, 12:30 – 13:15 CET
  • Chairs: Pietro Lampertico (Italy), Frank Tacke (Germany)

New guidelines on the 'Management of Acute (fulminant) Liver Failure'

  • Session title: CPG session – ALF, PSC, PBC
  • Time and date of presentation: Sunday 23 April 2017, 10:30 – 11:30 CET
  • Chair: Marco Marzioni (Italy)

New ESGE/EASL guidelines on the 'Role of endoscopy in Primary Sclerosing Cholangitis'

  • Session title: CPG session – ALF, PSC, PBC
  • Time and date of presentation: Sunday 23 April 2017, 10:30 – 11:30 CET
  • Chair: Marco Marzioni (Italy)

New guidelines on 'The treatment and management of patients with Primary Biliary Cholangitis'

  • Session title: CPG session – ALF, PSC, PBC
  • Time and date of presentation: Sunday 23 April 2017, 10:30 – 11:30 CET
  • Chair: Marco Marzioni (Italy)

"The EASL Primary Biliary Cholangitis guidelines are meant to support clinicians in establishing a long-term commitment with patients and their disease, providing indications on how to stratify the risk from diagnosis to disease progression. The guidelines will also help identify which patients require second line treatment, in which advances are fortunately being made," said Prof Marco Marzioni, Professor of Gastroenterology, Università Politecnica delle Marche – "Ospedali Riuniti" University Hospital of Ancona, Italy and one of the authors of the guidelines. He continued, "The EASL-ESGE guidelines have been developed by the two societies to identify the optimal approach for the management of Primary Sclerosing Cholangitis. As extra-hepatic bile ducts are involved in the disease, a multi-disciplinary approach is a key factor for the success of management. The guidelines provide a tool to fine tune the endoscopic and medical treatments of patients with Primary Sclerosing Cholangitis."

###

About The International Liver Congress™

This annual congress is the biggest event in the EASL calendar, attracting scientific and medical experts from around the world to learn about the latest in liver research. Attending specialists present, share, debate and conclude on the latest science and research in hepatology, working to enhance the treatment and management of liver disease in clinical practice. This year, the congress is expected to attract approximately 10,000 delegates from all corners of the globe. The International Liver Congress™ 2017 will take place from April 19 – 23, at the RAI Amsterdam, Amsterdam, The Netherlands.

About the Journal of Hepatology

The Journal of Hepatology is the official journal of the European Association for the Study of the Liver (EASL). It publishes original papers, reviews, case reports, and letters to the Editor concerned with clinical and basic research in the field of hepatology. http://www.journal-of-hepatology.eu

About The European Association for the Study of the Liver (EASL)

Since its foundation in 1966, this not-for-profit organisation has grown to over 4,000 members from all over the world, including many of the leading hepatologists in Europe and beyond. EASL is the leading liver association in Europe, having evolved into a major European Association with international influence, with an impressive track record in promoting research in liver disease, supporting wider education and promoting changes in European liver policy.

Contact

For more information, please contact the ILC Press Office at:

Email: [email protected]

Telephone: +44 (0)7841 009 252

Media Contact

ILC press office
[email protected]
44-078-410-09252
@EASLnews

http://www.easl.ch/

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

Cardiovascular Disease Influences Colorectal Cancer Outcomes

September 30, 2025

NRF2 Enhances Ovarian Cancer Cell Migration via TAGLN

September 30, 2025

Family, Clinician Views on CHD LIFE Care Pathway

September 30, 2025

LncRNA LOXL1-AS1 Boosts Ovarian Cancer via BRIP1

September 30, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    88 shares
    Share 35 Tweet 22
  • Physicists Develop Visible Time Crystal for the First Time

    74 shares
    Share 30 Tweet 19
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    60 shares
    Share 24 Tweet 15
  • Scientists Discover and Synthesize Active Compound in Magic Mushrooms Again

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cardiovascular Disease Influences Colorectal Cancer Outcomes

NRF2 Enhances Ovarian Cancer Cell Migration via TAGLN

Family, Clinician Views on CHD LIFE Care Pathway

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.